Cargando…

T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker

SIMPLE SUMMARY: Radiotherapy constitutes an essential component of the treatment for malignant disease. Besides its direct effect on cancer cells, namely, DNA damage and cell death, ionizing irradiation also mediates indirect antitumor effects that are mostly mediated by the immune system. Investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxevanis, Constantin N., Gritzapis, Angelos D., Voutsas, Ioannis F., Batsaki, Panagiota, Goulielmaki, Maria, Adamaki, Maria, Zoumpourlis, Vassilios, Fortis, Sotirios P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179913/ https://www.ncbi.nlm.nih.gov/pubmed/35681654 http://dx.doi.org/10.3390/cancers14112674

Ejemplares similares

The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer
por: Goulielmaki, Maria, et al.
Publicado: (2022)

Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
por: Thomaidou, Arsinoe C., et al.
Publicado: (2022)

DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
por: Papalouka, Chara, et al.
Publicado: (2023)

Radiotherapy-Related Gene Signature in Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2022)

A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2023)

Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
por: Kogionou, Paraskevi, et al.
Publicado: (2023)

Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
por: Goulielmaki, Maria, et al.
Publicado: (2023)

Combination Immunotherapy in Prostate Cancer
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

The thin red line between the immune system and cancer evolution
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance
por: Fortis, Sotirios P., et al.
Publicado: (2022)

Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer
por: Adamaki, Maria, et al.
Publicado: (2021)

Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
por: Fortis, Sotirios P, et al.
Publicado: (2015)

The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome
por: Stokidis, Savvas, et al.
Publicado: (2023)

Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head–Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay
por: Koukourakis, Michael I., et al.
Publicado: (2023)

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
por: Liouta, Galateia, et al.
Publicado: (2023)

Suitability of Human Mesenchymal Stem Cells Derived from Fetal Umbilical Cord (Wharton’s Jelly) as an Alternative In Vitro Model for Acute Drug Toxicity Screening
por: Christodoulou, Ioannis, et al.
Publicado: (2022)

The COVID-19 pandemic as a scientific and social challenge in the 21st century
por: Zoumpourlis, Vassilios, et al.
Publicado: (2020)

Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies
por: Drillis, Georgios, et al.
Publicado: (2021)

Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design
por: Baxevanis, Constantin N., et al.
Publicado: (2020)

Nutrient insufficiencies and deficiencies involved in the pathogenesis of bruxism (Review)
por: Pavlou, Ioannis A., et al.
Publicado: (2023)

Historical retrospective of the SRC oncogene and new perspectives (Review)
por: Simatou, Aristofania, et al.
Publicado: (2020)

miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy
por: Thomaidou, Arsinoe C., et al.
Publicado: (2023)

CircRNAs in Malignant Tumor Radiation: The New Frontier as Radiotherapy Biomarkers
por: Wu, Xixi, et al.
Publicado: (2022)

Significance of taurine transporter (TauT) in homeostasis and its layers of regulation
por: Baliou, Stella, et al.
Publicado: (2020)

Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
por: Christodoulou, Ioannis, et al.
Publicado: (2018)

Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide
por: Voutsas, Ioannis F., et al.
Publicado: (2016)

Bromamine T, a stable active bromine compound, prevents the LPS-induced inflammatory response
por: Baliou, Stella, et al.
Publicado: (2021)

HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer
por: Stokidis, Savvas, et al.
Publicado: (2020)

The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis
por: Tsintarakis, Antonis, et al.
Publicado: (2023)

Expression analysis of novel biomarkers for breast cancer
por: Laversin, SA, et al.
Publicado: (2008)

Genetically-modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)-based targeted therapy (Review)
por: Devetzi, Marina, et al.
Publicado: (2018)

CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
por: Baliou, Stella, et al.
Publicado: (2018)

Role of the CRISPR system in controlling gene transcription and monitoring cell fate
por: Baliou, Stella, et al.
Publicado: (2018)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo
por: Gritzapis, A D, et al.
Publicado: (2005)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Bromamine T (BAT) Exerts Stronger Anti-Cancer Properties than Taurine (Tau)
por: Baliou, Stella, et al.
Publicado: (2021)

Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets
por: Karagiannakos, Alexandros, et al.
Publicado: (2022)

DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties
por: Goulielmaki, Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fc19tdndv7923teph9iuvallgt